fda approved glp-1 agonists Comparing Ozempic, Wegovy and Other Drugs The Impact of GLP-1 Receptor
Description
Patent expiry in March 2026 invites further generics, potentially accelerating volume but pressuring branded margins within the Latin America GLP-1 agonists market
Lancet Reg Health Eur
Jun-ichi Miyazaki (University of Osaka, Japan) who produced the maternal MIN6 cell line
10.1111/j.1365-2036.2008.03870.x [DOI] [PubMed] [Google Scholar] 61.Li ZY, Zhang N, Wen S, Zhang J, Sun XL, Fan XM, Sun YH (2017) Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome
